Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine
Clinical trial NCT01817270 · COMPLETED
Trial details
- NCT number
- NCT01817270
- Sponsor
- Changchun Keygen Biological Products Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2013-08-01
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.